AVITA Medical (RCEL) Gross Profit (2018 - 2025)

AVITA Medical's Gross Profit history runs 8 years deep, the most recent figure standing at $14.3 million for Q4 2025.

• Quarterly Gross Profit fell 11.26% year-over-year to $14.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $58.8 million (up 6.63% YoY) and the FY2025 annual result came in at $58.8 million, up 6.63% from the prior year.
• Gross Profit was $14.3 million for Q4 2025 at AVITA Medical, up from $13.9 million in the prior quarter.
• Across five years, Gross Profit topped out at $20.8 million in Q3 2021 and bottomed at $5.8 million in Q1 2022.
• A 5-year average of $12.2 million and a median of $12.7 million in 2023 frame the typical range for Gross Profit.
• Annual changes were most pronounced in 2021 — Gross Profit soared 403.56% — and 2022, when it sank 63.65%.
• AVITA Medical's Gross Profit stood at $20.8 million in 2021, then plunged by 61.02% to $8.1 million in 2022, then jumped by 52.92% to $12.4 million in 2023, then soared by 30.06% to $16.1 million in 2024, then decreased by 11.26% to $14.3 million in 2025.
• Business Quant data shows RCEL's Gross Profit at $14.3 million in Q4 2025, $13.9 million in Q3 2025, and $14.9 million in Q2 2025.